1 documents found
Information × Registration Number 0216U000347, 0114U003143 , R & D reports Title To find out new predictors of the course of BCR-ABL negative chronic myeloproliferative neoplasms and to develop principles of risk adapted therapy popup.stage_title Head Maslyak Zvenyslava Volodymyrivna, Registration Date 29-01-2016 Organization LVIV RESEARCH INSTITUTE OF BLOOD PATHOLOGY AND TRANSFUSIONAL MEDICINE popup.description2 In the process of investigation a group of patients with chronic myeloproliferative neoplasms was formed, which included patients with idiopathic and secondary myelofibrosis, essential thrombocythemia and polycythemia vera. Patients were examined using clinical and additional laboratory methods, including specific cytogenetic and molecular genetic techniques. Based on a comprehensive study of hematopoietic cells karyotype, histological changes in the bone marrow, levels of proinflammatory and proangiogenic cytokines, JAK2 mutations in the course of BCR-ABL negative chronic myeloproliferative neoplasms, a set of differential diagnostic criteria for each nosology in this group are to be determined.5481 Product Description popup.authors Бойко Ольга Ігорівна Везденко Лідія Орестівна Виговська Ярослава Іллівна Даниш Ольга Йосипівна Кокоруз М. В. Котлярчук Констянтин Богданович Лозинська М. Р. Лозинський Ростислав Юрійович Масляк Звенислава Володимирівна Примак С. В. Сімонова М. І. Тераз С. С. popup.nrat_date 2020-04-02 Close
R & D report
To find out new predictors of the course of BCR-ABL negative chronic myeloproliferative neoplasms and to develop principles of risk adapted therapy
Head: Maslyak Zvenyslava Volodymyrivna. To find out new predictors of the course of BCR-ABL negative chronic myeloproliferative neoplasms and to develop principles of risk adapted therapy. (popup.stage: ). LVIV RESEARCH INSTITUTE OF BLOOD PATHOLOGY AND TRANSFUSIONAL MEDICINE. № 0216U000347
1 documents found

Updated: 2026-03-16


Роздрукувати цю сторінку